Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 19,403 shares at $79.44 ($1.5M) on 2024-07-31, disclosed to the SEC on 2024-08-02.
Scheduled sale ($1.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.02 | 896 | $69K | 4.5% |
| 2 | $77.02 | 896 | $69K | 4.5% |
| 3 | $78.05 | 597 | $47K | 3.0% |
| 4 | $79.44 | 5,723 | $455K | 29.5% |
| 5 | $79.44 | 5,723 | $455K | 29.5% |
| 6 | $80.38 | 1,649 |
| $133K |
| 8.6% |
| 7 | $80.38 | 1,649 | $133K | 8.6% |
| 8 | $81.31 | 1,135 | $92K | 6.0% |
| 9 | $81.31 | 1,135 | $92K | 6.0% |
| Total | $79.55 avg | 19,403 | $1.5M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |